Scioto Biosciences

Developer of therapies for diabetes, neurological disorders, gastrointestinal and others using probiotics

placeIndianapolis, Indiana, United States calendar_todayFounded 2017 groups10 employees language sciotobiosciences.com

Social engagement

Social engagement: 1.2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include VisionTech Partners, Genome & Company.

Investor typeCountShare
Venture capital650%
Accelerator & incubator18%
Other / undisclosed542%
Coming soon